clinicians; communities; computer modelling; in silico medicine; simulations; translation; trust in technology
Abstract :
[en] In silico medicine describes the application of computational modelling and simulation (CM&S) to the study, diagnosis, treatment or prevention of a disease. Tremendous research advances have been achieved to facilitate the use of CM&S in clinical applications. Nevertheless, the uptake of CM&S in clinical practice is not always timely and accurately reflected in the literature. A clear view on the current awareness, actual usage and opinions from the clinicians is needed to identify barriers and opportunities for the future of in silico medicine. The aim of this study was capturing the state of CM&S in clinics by means of a survey toward the clinical community. Responses were collected online using the Virtual Physiological Human institute communication channels, engagement with clinical societies, hospitals and individual contacts, between 2020 and 2021. Statistical analyses were done with R. Participants (n = 163) responded from all over the world. Clinicians were mostly aged between 35 and 64 years-old, with heterogeneous levels of experience and areas of expertise (i.e., 48% cardiology, 13% musculoskeletal, 8% general surgery, 5% paediatrics). The CM&S terms "Personalised medicine" and "Patient-specific modelling" were the most well-known within the respondents. "In silico clinical trials" and "Digital Twin" were the least known. The familiarity with different methods depended on the medical specialty. CM&S was used in clinics mostly to plan interventions. To date, the usage frequency is still scarce. A well-recognized benefit associated to CM&S is the increased trust in planning procedures. Overall, the recorded level of trust for CM&S is high and not proportional to awareness level. The main barriers appear to be access to computing resources, perception that CM&S is slow. Importantly, clinicians see a role for CM&S expertise in their team in the future. This survey offers a snapshot of the current situation of CM&S in clinics. Although the sample size and representativity could be increased, the results provide the community with actionable data to build a responsible strategy for accelerating a positive uptake of in silico medicine. New iterations and follow-up activities will track the evolution of responses over time and contribute to strengthen the engagement with the medical community.
Disciplines :
Engineering, computing & technology: Multidisciplinary, general & others
Author, co-author :
Lesage, Raphaëlle; Virtual Physiological Human Institute, Leuven, Belgium
Van Oudheusden, Michiel; Centre for Sociological Research, Life Sciences and Society Lab, KU Leuven, Leuven, Belgium
Schievano, Silvia; UCL Institute of Cardiovascular Science & Great Ormond Street Hospital for Children, London, United Kingdom ; Cardiorespiratory Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
Van Hoyweghen, Ine; Centre for Sociological Research, Life Sciences and Society Lab, KU Leuven, Leuven, Belgium
Geris, Liesbet ; Université de Liège - ULiège > Département d'aérospatiale et mécanique > Génie biomécanique ; Virtual Physiological Human Institute, Leuven, Belgium ; Prometheus, Division of Skeletal Tissue Engineering Leuven, KU Leuven, Leuven, Belgium ; Biomechanics Section, KU Leuven, Leuven, Belgium
Capelli, Claudio; UCL Institute of Cardiovascular Science & Great Ormond Street Hospital for Children, London, United Kingdom ; Cardiorespiratory Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
Language :
English
Title :
Mapping the use of computational modelling and simulation in clinics: A survey.
Moore JA Rutt BK Karlik SJ Yin K Ross Ethier C. Computational blood flow modeling based on in vivo measurements. Ann Biomed Eng. (1999) 27(5):627–40. 10.1114/1.22110548332
Taylor CA Hughes TJ Zarins CK. Finite element modeling of blood flow in arteries. Comput Methods Appl Mech Eng. (1998) 158(1-2):155–96. 10.1016/S0045-7825(98)80008-X
Eldabi T Paul RJ Young T. Simulation modelling in healthcare: reviewing legacies and investigating futures. J Oper Res Soc. (2007) 58(2):262–70. 10.1057/palgrave.jors.2602222
Zhou X Bueno-Orovio A Rodriguez B. In silico evaluation of arrhythmia. Curr Opin Physiol. (2018) 1:95–103. 10.1016/j.cophys.2017.11.003
Taylor CA Figueroa CA. Patient-specific modeling of cardiovascular mechanics. Annu Rev Biomed Eng. (2009) 11:109. 10.1146/annurev.bioeng.10.061807.16052119400706
Viceconti M Hunter P. The virtual physiological human: ten years after. Annu Rev Biomed Eng. (2016) 18:103–23. 10.1146/annurev-bioeng-110915-11474227420570
Capelli C Sauvage E Giusti G Bosi GM Ntsinjana H Carminati M et al. Patient-specific simulations for planning treatment in congenital heart disease. Interface Focus. (2018) 8(1):20170021. 10.1098/rsfs.2017.002129285347
Kwon SS Chung EC Park JS Kim GT Kim JW Kim KH et al. A novel patient-specific model to compute coronary fractional flow reserve. Prog Biophys Mol Biol. (2014) 116(1):48–55. 10.1016/j.pbiomolbio.2014.09.00325256102
Sack KL Davies NH Guccione JM Franz T. Personalised computational cardiology: patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction. Heart Fail Rev. (2016) 21(6):815–26. 10.1007/s10741-016-9528-926833320
Shublaq N Sansom C Coveney PV. Patient-specific modelling in drug design, development and selection including its role in clinical decision-making. Chem Biol Drug Des. (2013) 81(1):5–12. 10.1111/j.1747-0285.2012.01444.x22765044
Powathil GG Swat M Chaplain MA. Systems oncology: towards patient-specific treatment regimes informed by multiscale mathematical modelling. In: Seminars in cancer biology. Academic Press (2015), Vol. 30. p. 13–20.
Pankaj P. Patient-specific modelling of bone and bone-implant systems: the challenges. Int J Numer Method Biomed Eng. (2013) 29(2):233–49. 10.1002/cnm.253623281281
In vivo, in vitro, in silico. Why computer modelling is the next evolution of the healthcare sector. In proceedings of the international avicenna alliance conference; 4 September 2018; Brussels, Belgium, Available at: https://avicenna-alliance.com/files/user_upload/Conference_2018/materials/International_Avicenna_Alliance_Conference_Report_-_4_Sept._2018__final_.pdf (Accessed December 22, 2021).
Viceconti M Henney A Morley-Fletcher E. In silico clinical trials: how computer simulation will transform the biomedical industry. Int J Clin Trials. (2016) 3(2):37–46. 10.18203/2349-3259.ijct20161408
Gomes GT Van Cauter S De Beule M Vigneron L Pattyn C Audenaert EA. Patient-specific modelling in orthopedics: from image to surgery. In: Biomedical imaging and computational modeling in biomechanics. Dordrecht: Springer (2013). p. 109–29.
Eggermont F Van Der Wal G Westhoff P Laar A De Jong M Rozema T et al. Patient-specific finite element computer models improve fracture risk assessments in cancer patients with femoral bone metastases compared to clinical guidelines. Bone. (2020) 130:115101. 10.1016/j.bone.2019.11510131655223
Caroli A Manini S Antiga L Passera K Ene-Iordache B Rota S et al. Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients. Kidney Int. (2013) 84(6):1237–45. 10.1038/ki.2013.18823715122
de Jaegere P Rocatello G Prendergast BD de Backer O Van Mieghem NM Rajani R. Patient-specific computer simulation for transcatheter cardiac interventions: what a clinician needs to know. Heart. (2019) 105(Suppl 2):S21–S7. 10.1136/heartjnl-2018-31351430846521
Carlier A Vasilevich A Marechal M de Boer J Geris L. In silico clinical trials for pediatric orphan diseases. Sci Rep. (2018) 8(1):1–9. 10.1038/s41598-018-20737-y29311619
Pappalardo F Russo G Tshinanu FM Viceconti M. In silico clinical trials: concepts and early adoptions. Brief Bioinformatics. (2019) 20(5):1699–708. 10.1093/bib/bby04329868882
Favre P Maquer G Henderson A Hertig D Ciric D Bischoff JE. In silico clinical trials in the orthopedic device industry: from fantasy to reality? Ann Biomed Eng. (2021) 49(12):3213–26. 10.1007/s10439-021-02787-y33973129
Huberts W Heinen SG Zonnebeld N van den HD de Vries JP Tordoir JH et al. What is needed to make cardiovascular models suitable for clinical decision support? A viewpoint paper. J Comput Sci. (2018) 24:68–84. 10.1016/j.jocs.2017.07.006
Reddy S. Explainability and artificial intelligence in medicine. Lancet Digital Health. (2022) 4(4):e214–e5. 10.1016/S2589-7500(22)00029-235337639
Avril S Gee MW Hemmler A Rugonyi S. Patient-specific computational modeling of endovascular aneurysm repair: state of the art and future directions. Int J Numer Method Biomed Eng. (2021) 37(12):e3529. 10.1002/cnm.352934490740
Saravi B Hassel F Ülkümen S Zink A Shavlokhova V Couillard-Despres S et al. Artificial intelligence-driven prediction modeling and decision making in spine surgery using hybrid machine learning models. J Pers Med. (2022) 12(4):509. 10.3390/jpm1204050935455625
Yu Y Safdar S Bourantas G Zwick B Joldes G Kapur T et al. Automatic framework for patient-specific modelling of tumour resection-induced brain shift. Comput Biol Med. (2022) 143:105271. 10.1016/j.compbiomed.2022.10527135123136
Frederix I Caiani EG Dendale P Anker S Bax J Böhm A et al. ESC e-Cardiology working group position paper: overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiol. (2019) 26(11):1166a–77.
